ESSA Pharma Inc. (EPIX) Shareholder/Analyst Call Prepared Remarks Transcript
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025
Essa Pharma (EPIX) Nosedives 66% Ahead of Business Shutdown
Essa Pharma Inc. Clarifies Nasdaq Due Bill Trading for Previously Announced Cash Distribution
Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution
ESSA Pharma: Fiscal Q3 Earnings Snapshot
Essa Pharma Inc. Announces US$80 Million Cash Distribution to Shareholders
ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
ESSA Pharma: Fiscal Q2 Earnings Snapshot
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
ESSA Pharma: Fiscal Q1 Earnings Snapshot
ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024
3 Promising US Penny Stocks With Market Caps Under $80M
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit?
ESSA Pharma: Fiscal Q4 Earnings Snapshot
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
ESSA Pharma And 2 Other US Penny Stocks To Watch
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.